A clinical trial to study of Brihtyadi Ghan vati and laghu panchmoola kwath prakshalan and taila pichu in paripluta yonivyapad wsr PID

A comparative clinical study to evaluate the effect of Brihtyadi Ghan vati with Laghu Panchmoola kwath prakshalan and taila pichu in Paripluta Yonivyapad wsr PID

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056761

Enrollment

Registered

2023-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N739- Female pelvic inflammatory disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1• Patient willing for trial. 2• Married women 3• lower abdomen pain 4• Low back pain. 5• Abnormal cervical or vaginal discharge 6• Dyspareunia

Exclusion criteria

Exclusion criteria: 1• Pregnant women 2• Unmarried 3• PID associated with prolapsed uterus. 4• Endometriosis/ Chocolate cyst. 5• Severe or chronic ill health condition like diabetes mellitus & Hypertension tuberculosis etc. 6• Acute PID & peritonitis, tubo- Ovarian abscess, Genital tumor & malignancy.

Design outcomes

Primary

Measure	Time frame
1)To assess the efficacy of Brihatyadi Ghan vati and Laghu Panchmula kwath prakshalan with taila pichu in management of Paripluta Yonivyapad 2)To assess the efficacy of trial therapy on subjective parameters like pain in lower abdomen low back pain vaginal discharge dyspareunia objective criteria like cervical motion tenderness fornix tendernessTimepoint: Final assessment will be done after completion of trial of 4 consecutive months (3 months with clinical therapy and 1 month drug free)	—

Measure

Time frame

1)To assess the efficacy of Brihatyadi Ghan vati and Laghu Panchmula kwath prakshalan with taila pichu in management of Paripluta Yonivyapad 2)To assess the efficacy of trial therapy on subjective parameters like pain in lower abdomen low back pain vaginal discharge dyspareunia objective criteria like cervical motion tenderness fornix tendernessTimepoint: Final assessment will be done after completion of trial of 4 consecutive months (3 months with clinical therapy and 1 month drug free)

—

Secondary

Measure	Time frame
To assess the efficacy of trial therapy on subjective parameters like pain in lower abdomen low back pain vaginal discharge dyspareunia objective criteria like cervical motion tenderness fornix tenderness USG finding ( fluid in pouch of Douglas)Timepoint: Follow up- Three follow up will be done at every 1month during the therapy	—

Countries

India

Contacts

Public ContactDrJaya Srivastava

State Ayurvedic college and hospital Lucknow UP

jayasrivas541@gmail.com9838436080

Outcome results